Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$68,863,682
-$24,865,384 QoQ
Shares Held
1,313,691
-22.6% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#35
of 1,033 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$77,480
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $4,776,233,341 across 18 Drug Manufacturers - General names. GSK ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
961,496 | $1,153,247,243 | |
| 2 | ABBV |
AbbVie Inc.
|
3,055,271 | $768,828,394 | |
| 3 | JNJ |
Johnson & Johnson
|
2,799,362 | $710,953,967 | |
| 4 | AMGN |
Amgen Inc
|
1,321,585 | $478,572,360 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,130,937 | $402,325,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,536,332 | $320,440,184 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,492,542 | $316,480,270 | |
| 8 | PFE |
Pfizer Inc
|
10,704,871 | $257,773,293 |
All Filings in GSK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,863,682 | 1,313,691 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $93,729,066 | 1,698,298 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $18,482,048 | 376,877 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,984,108 | 45,971 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $437,721 | 11,399 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $77,480 | 2,000 | Put | Defined | 2025-05-14 | |
| 2025-03-31 | $775,923 | 20,029 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $12,422,593 | 367,315 | Shares | Defined | 2025-02-14 | |
| 2022-06-30 | $171,753,611 | 4,022,877 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $170,725,278 | 3,996,037 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $167,396,811 | 3,870,153 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $225,048,925 | 6,005,089 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $234,771,328 | 6,011,230 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $454,151 | 12,974 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $1,724,147 | 47,769 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $341,263 | 9,244 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $386,786 | 9,668 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $272,326 | 7,328 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||